InDex Pharmaceuticals is attending the UEGW 2023 congress

Contributed by: PR Newswire

Tags

InDex-Pharmaceuticals

More Like This

InDex Pharmaceuticals has been granted a new patent for cobitolimod in South Korea

InDex Pharmaceuticals discontinues cobitolimod phase III program

InDex Pharmaceuticals announces that all patients needed for the cobitolimod dose selection milestone have completed Induction Study 1 of the phase III program CONCLUDE

InDex Pharmaceuticals announces expected cash balance per March 31, 2024

Business Wire logo

Incyte to Highlight Data From its Oncology Portfolio at the 2024 ASCO Annual Meeting and EHA2024 Congress

Calliditas Therapeutics to Present Nefecon Data at the ISN World Congress of Nephrology April 13 - 16 in Buenos Aires

Calliditas Therapeutics to Present Data at ERA 2024 May 23 - 26 in Stockholm

Calliditas Therapeutics to Present Seven Abstracts at the American Society of Nephrology (ASN) Kidney Week 2023